Healthcare Technology & Innovation Index
|Primary Index Series||Live Date||Index Ticker||Download Fact Sheet|
|ROBO Global® Healthcare Technology & Innovation Index||4/30/19||HTEC|
All indices are in USD except where indicated otherwise.
Price Return and Total Net Returns versions are available.
For each index, 10 years of past performance history is available.
For information on licensing any of these indices, please contact email@example.com.
ROBO Global Sub Index Series
|Sub Index Series||Sub Index Series Name||Live Date||Index Ticker|
Massive disruption is taking the healthcare space by storm. Rapidly evolving technologies are quietly and completely morphing the medical field as we know it. Robotics, artificial intelligence, and healthcare technologies are becoming significant change agents in the industry and investors should be taking notice.
HTEC provides unique, global exposure to best-in-class companies leading the healthcare technology revolution, across diagnostics, robotics, genomics, precision and regenerative medicine, lab automation, instruments, data analytics, and telehealth.
The data shown is derived from the published index values.
Data prior to 30 April 2019 is based on simulated back-tested data.
Unique Quarterly Process for Company Inclusion
The ROBO Global Index includes more than 80 stocks across 12 subsectors in 14 countries. The Index is built to minimize risk by limiting reliance on the largest-cap players, and it is carefully structured to capture the growth of rapidly developing robotics and automation companies around the globe.
The ROBO Global® Industry Classification system includes 9 subsectors of suitable product and technology maturity to the Healthcare Technology and Innovation theme that carry high growth and earnings potential. The result is an investible universe of market leaders with strong growth prospects and revenue generation across the landscape of healthcare technology.
Providers of robotic-assisted platforms, including robots used for surgical and diagnostic applications, sterilization, and product delivery.
Providers of next-generation medical instruments, including surgical tools, implantable devices and other instruments for the treatment of chronic and life-threatening illnesses.
Software and solution providers that use data analytics and machine learning to support clinical trials, manage medical information and care providers’ workflows.
Specialists in virtual care and remote monitoring, including virtual doctor visits, mobile and wearable devices.
Providers of solutions for the regeneration of cells, tissue and organs, such as tissue engineering, organ and bone transplants, and plasma therapies.
Providers of custom therapies based on genetic, environmental, lifestyle, and other key factors.
Providers of technology for the analysis of genetic data, including next-generation gene sequencing tools used to help predict the risk of genetic diseases, detect cancer and improve the application of precision medicine.
Providers of automation solutions for laboratory processes, including information and sample management, fluid handling, outsourced lab services and more.
Providers of advanced tools, software, and services for medical diagnosis, including next-generation imagery and molecular testing.
The ROBO Global Healthcare Technology & Innovation Index includes more than 80 stocks across 9 subsectors in 15 countries. The Index is built to minimize risk by limiting reliance on the largest-cap players, and to capture the growth of rapidly developing healthcare technology companies around the globe.
Market Capitalization Breakdown
Meet the Growth Drivers
Meet the companies inside the ROBO Global Healthcare Technology & Innovation Index
Turnkey Tech Investing: January 2020 Market Brief
Turnkey Tech Investing: December 2019 Market Brief
At Rockwell Automation, all eyes are on innovation and growth
ROBO Global registers as benchmark administrator under BMR
Turnkey Tech Investing: September 2019 Market Brief
Shopify & 6 River: Game-Changing M&A in Warehouse Automation
Qiagen: The most ubiquitous company in molecular diagnostics
Tecan: Enabling the disruption of life science and diagnostics
AeroVironment: Changing the landscape of precision agriculture
ABB exits Power Grids and paves the way for accelerated growth